A Phase I Trial of AZD3965 in Patients With Advanced Cancer

NCT01791595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Adult Solid Tumor
Diffuse Large B Cell Lymphoma
Burkitt Lymphoma

Interventions

DRUG: AZD3965
DRUG: AZD3965
DRUG: AZD3965
DRUG: AZD3965
DRUG: AZD3965
DRUG: AZD3965
DRUG: AZD3965

Sponsor

Cancer Research UK

Collaborators

[object Object]